In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization

Virology

Volumn 332, Issue 1, 2005, Pages 28-37

  Lowe, Devin B ^a   Shearer, Michael H ^a   Tarbox, James A ^a   Kang, Hyun Seok ^a   Jumper, Cynthia A ^a,b   Bright, Robert K ^a   Kennedy, Ronald C ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer immunology; DNA immunization; Simian virus 40 large tumor antigen

Indexed keywords

CANCER VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; PLASMID DNA; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIMIAN VIRUS 40; T LYMPHOCYTE; TRANSGENE; TUMOR IMMUNITY;

ANIMALS; ANTIBODIES, NEOPLASM; ANTIGENS, POLYOMAVIRUS TRANSFORMING; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; IMMUNIZATION; MICE; MICE, INBRED BALB C; SARCOMA, EXPERIMENTAL; SIMIAN VIRUS 40; VACCINES, DNA;

MURINAE; SIMIAE; SIMIAN VIRUS 40;

EID: 12344269700     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.08.041     Document Type: Article

References (30)

1. D.H. Barouch, S. Santra, K. Tenner-Racz, P. Racz, M.J. Kuroda, J.E. Schmitz, S.S. Jackson, M.A. Lifton, D.C. Freed, H.C. Perry, M.-E. Davies, J.W. Shiver, and N.L. Letvin Potent CD4+ T cell responses elicited by a Bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF J. Immunol. 168 2002 562 568
2. P.A. Benton, and R.C. Kennedy DNA vaccine strategies for the treatment of cancer Curr. Top. Microbiol. Immunol. 226 1998 1 20
3. C.M. Boyle, M. Morin, R.G. Webster, and H.L. Robinson Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoprotein J. Virol. 70 1996 9074 9078
4. R.K. Bright, M.H. Shearer, and R.C. Kennedy Comparison of the murine humoral immune response to simian virus 40 large tumor antigen: epitope specificity and idiotype expression Cancer Immunol. Immunother. 37 1993 31 39
5. R.K. Bright, M.H. Shearer, and R.C. Kennedy Immunization of BALB/c mice with recombinant Simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against Simian virus 40-transformed cells J. Immunol. 153 1994 2064 2071
6. R.K. Bright, B. Beames, M.H. Shearer, and R.C. Kennedy Protection against a lethal tumor challenge with simian virus 40 transformed cells by the direct injection of DNA encoding simian virus 40 large tumor antigen Cancer Res. 56 1996 1126 1130
7. R.K. Bright, E.T. Kimchi, M.H. Shearer, R.C. Kennedy, and H.I. Pass SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients Cancer Immunol. Immunother. 50 2002 682 690
8. J.S. Butel, and J.A. Lednicky Cell and molecular biology of Simian virus 40: implications for human infections and disease J. Natl. Cancer Inst. 91 1999 119 134
9. M.K. Foecking, and H. Hofstetter Powerful and versatile enhancer-promoter unit for mammalian expression vectors Gene 45 1986 101 105
10. T.A. Galvin, J. Muller, and A.S. Khan Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina Vaccine 22 2000 2566 2583
11. R.C. Kennedy, M.H. Shearer, A.M. Watts, and R.K. Bright CD4+ T lymphocytes play a critical role in antibody production and tumor immunity Cancer Res. 63 2003 1040 1046
12. S. Kit, T. Kurimura, and D. Dubs Transplantable mouse tumour line induced by injection of SV40-transformed mouse kidney cells Int. J. Cancer 4 1969 384 392
13. N. Michel, W. Osen, L. Gissmann, T.N.M. Schumacher, H. Zentgraf, and M. Muller Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccinations Virology 294 2002 47 59
14. A.F. Ochsenbein, P. Klenerman, U. Karrer, B. Ludewig, M. Pericin, H. Hengartner, and R.M. Zinkernagel Immune surveillance against a solid tumor fails because of immunological ignorance Proc. Natl. Acad. Sci. U.S.A. 96 1999 2233 2238
15. A.F. Ochsenbein, S. Sierro, B. Odermatt, M. Pericin, U. Karrer, J. Hermans, S. Hemmi, H. Hengartner, and R.M. Zinkernagel Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction Nature 411 2001 1058 1064
16. A. Quinn, W. Jiang, M. Velaz-Faircloth, A. Cobb, S. Henry, and R. Frothingham In vivo protein expression and immune responses generated by DNA vaccines expressing mycobacterial antigens fused with a reporter protein Vaccine 20 2002 3187
17. A. Reyes-Sandoval, and H.C. Ertl DNA vaccines Curr. Mol. Med. 1 2001 217 243
18. P. Rizzo, M. Bocchetta, A. Powers, R. Foddis, E. Stekala, H.I. Pass, and M. Carbone SV40 and the pathogenesis of mesothelioma Semin. Cancer Biol. 11 2001 63 71
19. R.A. Seder, and R. Ahmed Similarities and differences in CD+ and CD+ effector and memory cell generation Nat. Immunol. 4 2003 835 842
20. M.H. Shearer, R.E. Lanford, and R.C. Kennedy Monoclonal antiidiotypic antibodies induce humoral immune responses specific for simian virus 40 large tumor antigen in mice J. Immunol. 145 1990 932 939
21. M.H. Shearer, R.K. Bright, and R.C. Kennedy Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype Cancer Res. 53 1993 5734 5739
22. J.I. Sin, and D.B. Weiner Improving DNA vaccines targeting viral infections Intervirology 43 2000 233 246
23. P.J. Southern, and P. Berg Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter J. Mol. Appl. Genet. 1 1982 327 341
24. O. Utermohlen, C. Schulze-Garg, G. Warnecke, R. Gugel, J. Lohlor, and W. Deppert Simian Virus 40 large T antigen specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor associated, tumor specific CD8+ cytotoxic T lymphocytes and CD4+ T helper cells J. Virol. 75 2001 10593 10602
25. A.M. Watts, M.H. Shearer, H.I. Pass, and R.C. Kennedy Development of an experimental murine pulmonary metastasis model incorporating a viral encoded tumor specific antigen J. Virol. Methods 69 1997 93 102
26. A.M. Watts, M.H. Shearer, H.I. Pass, and R.C. Kennedy Comparison of SV40 large T-ag recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis model Cancer Immunol. Immunother. 47 1999 343 351
27. E.J. Wherry, K.A. Puorro, A. Porgador, and L.C. Eisenlohr The induction of virus specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitopes are attained J. Immunol. 163 1999 3735 3745
28. H. Wolf, R.Q. Warren, G.W. Stunz, K.R. Shuler, P. Kanda, and R.C. Kennedy Fine specificity of the murine antibody response to HIV-1 gp160 determined by synthetic peptides which define selected epitopes Mol. Immunol. 29 1992 989 998
29. K.J. Wood, and S. Sakaguchi Regulatory T cells in transplantation tolerance Nat. Rev., Immunol. 3 2003 199 257
30. Z.-L. Xu, H. Mizuguchi, A. Ishii-Watabe, E. Uchida, T. Mayumi, and T. Hayakawa Optimization of transcriptional regulatory elements for constructing plasmid vectors Gene 272 2001 149 156